Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 232

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study

Open access
Kim, Donghee, Adeniji, Nia, Latt, Nyann, Kumar, Sonal, Bloom, Patricia P., Aby, Elizabeth S., Perumalswami, Ponni, Roytman, Marina, Li, Michael, Vogel, Alexander S., Catana, Andreea M., Wegermann, Kara, Carr, Rotonya M., Aloman, Costica, Chen, Vincent L., Rabiee, Atoosa, Sadowski, Brett, Nguyen, Veronica, Dunn, Winston, Chavin, Kenneth D., Zhou, Kali, Lizaola-Mayo, Blanca, Moghe, Akshata, Debes, José, Lee, Tzu-Hao, Branch, Andrea D., Viveiros, Kathleen, Chan, Walter, Chascsa, David M., Kwo, Paul, Dhanasekaran, Renumathy · 2021 · Clinical Gastroenterology and Hepatology

Abstract

Background & Aims Chronic liver disease (CLD) represents a major global health burden. We undertook this study to identify the factors associated with adverse outcomes in patients with CLD who acquire the novel coronavirus-2019 (COVID-19). Methods We conducted a multi-center, observational cohort study across 21 institutions in the United States (US) of adult patients with CLD and laboratory-confirmed diagnosis of COVID-19 between March 1, 2020 and May 30, 2020. We performed survival analysis to identify independent predictors of all-cause mortality and COVID-19 related mortality, and multivariate logistic regression to determine the risk of severe COVID-19 in patients with CLD. Results Of the 978 patients in our cohort, 867 patients (mean age 56.9 ± 14.5 years, 55% male) met inclusion criteria. The overall all-cause mortality was 14.0% (n = 121), and 61.7% (n = 535) had severe COVID-19. Patients presenting with diarrhea or nausea/vomiting were more likely to have severe COVID-19. The liver-specific factors associated with independent risk of higher overall mortality were alcohol-related liver disease (ALD) (hazard ratio [HR] 2.42, 95% confidence interval [CI] 1.29–4.55), decompensated cirrhosis (HR 2.91 [1.70–5.00]) and hepatocellular carcinoma (HCC) (HR 3.31 [1.53–7.16]). Other factors were increasing age, diabetes, hypertension, chronic obstructive pulmonary disease and current smoker. Hispanic ethnicity (odds ratio [OR] 2.33 [1.47–3.70]) and decompensated cirrhosis (OR 2.50 [1.20–5.21]) were independently associated with risk for severe COVID-19. Conclusions The risk factors which predict higher overall mortality among patients with CLD and COVID-19 are ALD, decompensated cirrhosis and HCC. Hispanic ethnicity and decompensated cirrhosis are associated with severe COVID-19. Our results will enable risk stratification and personalization of the management of patients with CLD and COVID-19. Clinicaltrials.gov number NCT04439084

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2020.09.027

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 232

Metadata

Authors
Kim, D., Adeniji, N., Latt, N., Kumar, S., Bloom, P. P., Aby, E. S., Perumalswami, P., Roytman, M., Li, M., Vogel, A. S., Catana, A. M., Wegermann, K., Carr, R. M., Aloman, C., Chen, V. L., Rabiee, A., Sadowski, B., Nguyen, V., Dunn, W., Chavin, K. D., Zhou, K., Lizaola-Mayo, B., Moghe, A., Debes, J., Lee, T.-H., Branch, A. D., Viveiros, K., Chan, W., Chascsa, D. M., Kwo, P., & Dhanasekaran, R.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2021-07
Volume
19
Issue
7
Pages
1469-1479.e19
ISSN
1542-3565 (ISSN-L)
OpenAlex
W3085849982
Cited by
232
References
7
FWCI
5.82
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.